Janet Huffman - 07 Mar 2023 Form 4 Insider Report for ORAGENICS INC (OGEN)

Role: CFO, Secretary and Treasurer
Signature: /s/ Mark A. Catchur, as Attorney-in-Fact for Janet Huffman
Issuer symbol: OGEN
Transactions as of: 07 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 08 Mar 2023, 15:31:44 UTC
Previous filing: 24 Feb 2023
Next filing: 10 Aug 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OGEN	Employee Option (Right to Buy)	Award	$0	+7,000		$0.000000	7,000	07 Mar 2023	Common Stock	7,000	$4.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan in connection with the engagement to serve as the Company's Chief Financial Officer. The options vest as follows: 1,400 options vest on the grant date, 1,400 options vest on September 7, 2023, 1,400 options vest on March 7, 2024, 1,400 options vest on September 7, 2024, and 1,400 options vest on March 7, 2025. The option exercise price is the Company's closing price on the date of grant.

Content

Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan in connection with the engagement to serve as the Company's Chief Financial Officer. The options vest as follows: 1,400 options vest on the grant date, 1,400 options vest on September 7, 2023, 1,400 options vest on March 7, 2024, 1,400 options vest on September 7, 2024, and 1,400 options vest on March 7, 2025. The option exercise price is the Company's closing price on the date of grant.